货号:A365920
同义名:
Avexitide; Exendin (9-39)
Exendin(9-39) amide是胰高血糖素样肽-1(GLP-1)受体的拮抗剂,也能抑制葡萄糖依赖性胰岛素分泌肽(GIP)受体结合。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Glucagon-like peptide-1 (GLP-1) is a product of proglucagon cleavage synthesized in L cells in the intestinal mucosa, α-cells in the pancreatic islet, and neurons in the nucleus of the solitary tract. GLP-1 is released in response to nutrient absorption in the gut and helps to stimulate insulin secretion in the pancreaticb-cells while also suppressing glucagonsecretion[1]. GLP-1 plays a role in the control of fasting glucose. Avexitide (Exendin (9-39)), a truncated form of the GLP-1 agonist exendin-4, is a specific GLP-1 receptor antagonist. Exendin-(9-39) prevents hypoglycemia and maintains stability of blood glucose during a prolonged fast in individuals with KATPHI.[2]. It is an antagonist of the action of GLP-1(7-36) amide on arterial blood pressure and heart rate of rats. (3000ng of exendin 3-39 and 10ng of GLP-1 (7-36) amide)[3]. It inhibits exendin-3-induced increases in cAMP levels in guinea pig pancreas cells (IC50 = 20 nM)[4]. |
Concentration | Treated Time | Description | References | |
CD34+ HSPCs | 150 nM | Used as a GLP-1R antagonist to block the effects of LIRA | Cardiovasc Diabetol. 2022 Apr 9;21(1):51 | |
hTRPV1-expressing CHO K1 cells | 100 nM | Inhibited CAP-induced TRPV1 calcium influx | Exp Mol Med. 2024 Nov;56(11):2449-2464 | |
Mouse DRG neurons | 100 nM | Inhibited CAP-induced TRPV1 inward currents and calcium responses | Exp Mol Med. 2024 Nov;56(11):2449-2464 |
Administration | Dosage | Frequency | Description | References | ||
Mice | Wild-type mice, Gcg null mice, GLP-1R KO mice, GcgRAΔvilcre mice, GcgRAΔPDX1Cre mice | Intraperitoneal injection | 50μg/100μl | Single injection or 30-day continuous administration | Ex9 impaired glucose tolerance in wild-type mice but had no impact on Gcg null or GLP-1R KO mice suggesting that Ex9 is a true and specific GLP-1R antagonist. Unexpectedly, Ex-9 had no effect on blood glucose in mice with restoration of intestinal Gcg. In contrast, pancreatic reactivation of Gcg fully restored the effect of Ex9 to impair both oral and IP glucose tolerance. | Cell Metab. 2017 Apr 4;25(4):927-934. e3 |
Mice | CAP-induced acute pain model | Intraplantar injection | 5 and 10 μg | Single administration | Alleviated CAP-induced spontaneous pain behaviors | Exp Mol Med. 2024 Nov;56(11):2449-2464 |
Rats | Myocardial infarction model | Intravenous injection | 50 mg/kg | Single dose | Blockade of GLP-1 receptors abolished the protective effects of remote ischemic preconditioning and perconditioning | Cardiovasc Res. 2016 Dec;112(3):669-676 |
Mice | GcgRAΔNull, GcgRAΔVilCre, GcgRAΔPDX1Cre mice | Intraperitoneal injection | 50 μg/100 μl | Single dose | Exendin-[9–39] (Ex9) was used as a GLP-1 receptor antagonist to evaluate the role of GLP-1 in the glucose-lowering effects of DPP-4 inhibitors. Results showed that Ex9 did not affect glucose tolerance in GcgRAΔNull and GcgRAΔVilCre mice but blunted the glucose-lowering effect of linagliptin in GcgRAΔPDX1Cre mice. | Diabetologia. 2019 Oct;62(10):1928-1937 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
0.30mL 0.06mL 0.03mL |
1.48mL 0.30mL 0.15mL |
2.97mL 0.59mL 0.30mL |
CAS号 | 133514-43-9 |
分子式 | C149H234N40O47S |
分子量 | 3369.76 |
SMILES Code | C([C@H](NC([C@@H](NC([C@@H](NC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(O)=O)N)=O)CC(C)C)=O)CO)=O)CCCCN)=O)CCC(N)=O)=O)CCSC)=O)CCC(O)=O)=O)CCC(O)=O)=O)CCC(O)=O)=O)C)=O)[C@@H](C)C)=O)CCCNC(=N)N)=O)CC(C)C)=O)=O)[C@H](CC)C)=O)CCC(O)=O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(=O)N2[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(=O)N3[C@H](C(=O)N4[C@H](C(=O)N5[C@H](C(N[C@H](C(N)=O)CO)=O)CCC5)CCC4)CCC3)C)=O)=O)CO)=O)CO)=O)CCC2)=O)=O)CC(N)=O)=O)CCCCN)=O)CC(C)C)=O)C=6C=7C(NC6)=CC=CC7 |
MDL No. | MFCD02179664 |
别名 | Avexitide; Exendin (9-39); Exendin-3 (9-39) amide |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
溶解方案 |
H2O: 50 mg/mL(14.84 mM),配合低频超声助溶
|